| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 38.351 | 172.470 | 291.641 | 343.422 | 335.389 | 487.071 | 573.987 | 632.681 | 619.346 |
| Total Income - EUR | 0 | 38.359 | 172.554 | 292.608 | 344.033 | 337.915 | 488.682 | 585.766 | 638.602 | 621.208 |
| Total Expenses - EUR | 425 | 49.229 | 165.272 | 250.605 | 304.716 | 291.475 | 403.050 | 560.834 | 609.357 | 576.953 |
| Gross Profit/Loss - EUR | -425 | -10.871 | 7.282 | 42.003 | 39.317 | 46.440 | 85.633 | 24.932 | 29.245 | 44.254 |
| Net Profit/Loss - EUR | -425 | -11.574 | 5.557 | 39.403 | 36.378 | 43.610 | 81.956 | 20.355 | 21.789 | 37.318 |
| Employees | 0 | 2 | 3 | 4 | 4 | 5 | 4 | 7 | 7 | 5 |
Check the financial reports for the company - Dux Md Pharma Solutions S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 76 | 127 | 0 | 8.422 | 5.711 | 3.221 | 1.497 | 5.549 | 8.603 |
| Current Assets | 89 | 22.556 | 28.771 | 56.397 | 119.437 | 194.378 | 219.310 | 238.906 | 209.084 | 239.107 |
| Inventories | 7 | 9.448 | 12.970 | 17.859 | 42.556 | 88.741 | 77.911 | 63.065 | 90.814 | 122.835 |
| Receivables | 0 | 2.853 | 5.620 | 6.581 | 8.155 | 21.829 | 39.853 | 55.534 | 61.022 | 81.025 |
| Cash | 82 | 10.255 | 10.181 | 31.957 | 68.726 | 83.808 | 101.547 | 120.307 | 57.248 | 35.247 |
| Shareholders Funds | -380 | -11.950 | -6.181 | 33.335 | 69.067 | 111.985 | 180.299 | 21.009 | 20.111 | 37.366 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 469 | 34.583 | 35.121 | 23.231 | 59.728 | 89.282 | 43.449 | 221.209 | 196.510 | 213.259 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Dux Md Pharma Solutions S.r.l.